Label-free mass spectrometry assays: maximizing benefits without limitations

Mass spectrometry (MS) remains one of the most powerful label-free technologies for high-throughput screening. That’s why one pharma company enlisted a CRO with MS capabilities to run their next high-throughput screening campaign. However, they soon experienced the caveats of traditional MS approaches, including limited throughput and restrictive conditions, impacting data quality and timelines. Learn how Peapod Bio’s innovative approach to mass spectrometry offered key solutions, including the optimization of the assay based on the target rather than forcing the company to make compromises to utilize the MS instrument, delivering decision-driving data to identify their next drug leads.